Splenic Hilar Nodes in Splenic Flexure Cancer

• Conditions: Colon Cancer; Metastases, Lymphatic
• Interventions: Other: Review of records and follow up

• Registration Number: NCT04666883
• Lead Sponsor: University of Rome Tor Vergata

Brief Summary

Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-12
• Study First Submitted: 2020-12-08
• Study First Submitted QC: 2020-12-08
• Study First Posted: 2020-12-14
• Last Update Submitted: 2020-12-24
• Last Update Posted: 2020-12-29
• Study Start: 2021-01-01
• Primary Completion: 2021-03-01
• Study Completion: 2021-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• All splenic flexure cancer patients

Exclusion Criteria

• No consent to data utilization

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Splenic flexure cancer patients	Review of records and follow up	Splenic flexure cancer patients

Primary Outcome Measures

Name	Time	Method
Splenic hilum nodal metastases	5 years	Splenic hilum nodal metastases

Trial Locations

Locations (1)

Policlinico Tor Vergata; 🇮🇹 Roma, RM, Italy